Skip to main content

MYLAN 2045 MYLAN 2045 Pill - orange gray capsule/oblong, 14mm

Pill with imprint MYLAN 2045 MYLAN 2045 is Orange / Gray, Capsule/Oblong and has been identified as Tacrolimus 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Tacrolimus is used in the treatment of Organ Transplant, Rejection Prophylaxis; Organ Transplant, Rejection Reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2045 MYLAN 2045

Tacrolimus 0.5 mg MYLAN 2045 MYLAN 2045
Tacrolimus 0.5 mg MYLAN 2045 MYLAN 2045

Tacrolimus

Imprint
MYLAN 2045 MYLAN 2045
Strength
0.5 mg
Color
Orange / Gray
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Calcineurin inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, ferrosoferric oxide, silicon dioxide, croscarmellose sodium, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, sodium lauryl sulfate, titanium dioxide, ferric oxide yellow, D&C Red No. 28, D&C Yellow No. 10, FD&C Red No. 40, FD&C Blue No. 1, FD&C Blue No. 2, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2045 Mylan Pharmaceuticals Inc.
51079-0817 UDL Laboratories Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer